Regulatory

Year-End Report 2017

Board member Poul Erik Schou-Pedersen leaves the board at his own request

ChromoGenics secures funding for offensive market expansion – rights issue subscribed to 81.3 percent

Prospectus regarding ChromoGenics’ rights issue published

ChromoGenics’ rights issue of approximately MSEK 40 is guaranteed to approximately 80%, corresponding to approximately 33 MSEK

Resolutions at ChromoGenics AB’s (Publ) Extraordinary General Meeting

Notice of extraordinary general meeting in ChromoGenics

ChromoGenics targets an offensive market expansion and announces a rights issue with pre-emption rights of ca 40 MSEK

Interim report January – September 2017

ChromoGenics has appointed Åsa Stroofe as Chief Marketing Officer

Subscribe

Subscribe to our news